FDA Grants Breakthrough Therapy Designation to LSD-Based Treatment for Generalized Anxiety Disorder
Drug Topics
MARCH 7, 2024
Mind Medicine’s lysergide d-tartrate (MM120) demonstrated statistically significant and clinically meaningful improvements in anxiety symptoms in a phase 2b study.
Let's personalize your content